GENNOVA BIOPHARMACEUTICALS LTD has a total of 38 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are IMMUNOTOPE INC, VIROMETIX AG and ADVAXIS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | United States | 4 | |
#5 | Brazil | 3 | |
#6 | Mexico | 3 | |
#7 | Chile | 2 | |
#8 | EAPO (Eurasian Patent Organization) | 2 | |
#9 | New Zealand | 2 | |
#10 | Peru | 2 | |
#11 | China | 1 | |
#12 | Colombia | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Enzymes | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Climate change adaptation technologies | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials | |
#9 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Singh Sanjay | 27 |
#2 | Raghuwanshi Arjun | 16 |
#3 | Mishra Maheshwari Kumar | 8 |
#4 | Bhandari Pritiranjan | 8 |
#5 | Kardile Pavan | 7 |
#6 | Singh Shrawan Kumar | 7 |
#7 | Kumar Ankit | 7 |
#8 | Thaker Nidhiben | 7 |
#9 | Shankar Shagun | 7 |
#10 | Sahoo Ranjan Mihir | 6 |
Publication | Filing date | Title |
---|---|---|
UY38819A | OPHTHALMIC COMPOSITION OF BEVACIZUMAB | |
WO2019229764A1 | Process for production of recombinant tnk-tpa by packed-bed perfusion system | |
WO2020136666A1 | A lyophilized composition of pegaspargase | |
US2020308256A1 | Antibody phage display library | |
BR112017006294A2 | Innovative purification process for the isolation and commercial production of recombinant tnk-tpa (tenecteplase) | |
AU2015291123A1 | A novel process for purification of rHu-GCSF | |
NZ611706A | Pharmaceutical compositions of tenecteplase |